Furthermore, in patients with genetically undiagnosed hypomyelination, FOLR1 should be investigated promptly and included in all leukodystrophy panels to ensure early treatment with folinic acid and optimize clinical outcomes. Here, FOLR1 is linked to leukodystrophy.